Ondo, G. N., Ushijima, Y., Abe, H., Mahmoudou, S., Bikangui, R., Nkoma, A. M., Mbadinga, M. J. V. M., More, A., Agbanrin, M. D., Pemba, C. M., Beh Mba, R., Akim, A. A., Lell, B., & Yasuda, J. (2024). Genetic Diversity and Detection of Respiratory Viruses Excluding SARS-CoV-2 during the COVID-19 Pandemic in Gabon, 2020–2021. Viruses, 16(5), 698. Cite
Murayama, H., Endo, A., & Yonekura, S. (2023). Estimation of waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics. Epidemics, 45, 100726. Cite
Ngwe Tun, M. M., Luvai, E. A. C., Toizumi, M., Moriuchi, M., Takamatsu, Y., Inoue, S., Urano, T., Bui, M. X., Thai Hung, D., Thi Nguyen, H.-A., Anh, D. D., Yoshida, L.-M., Moriuchi, H., & Morita, K. (2024). Possible vertical transmission of Chikungunya virus infection detected in the cord blood samples from a birth cohort in Vietnam. Journal of Infection and Public Health, 17(6), 1050–1056. Cite
Asakura, T. R., Jung, S., Murayama, H., Ghaznavi, C., Sakamoto, H., Teshima, A., Miura, F., & Endo, A. (2024). Projecting international mpox spread in Asia: ongoing global health risk. medRxiv. Cite
Rimal, S., Shrestha, S., Paudel, S. W., Shah, Y., Bhandari, G., Pandey, K., Kharbuja, A., Kapandji, M., Gautam, I., Bhujel, R., Takamatsu, Y., Bhandari, R., Klungthong, C., Shrestha, S. K., Fernandez, S., Malavige, G. N., Pandey, B. D., Urano, T., Morita, K., … Dumre, S. P. (2024). Molecular and Entomological Characterization of 2023 Dengue Outbreak in Dhading District, Central Nepal. Viruses, 16(4), 594. Cite
Hartner, A.-M., Li, X., Echeverria-Londono, S., Roth, J., Abbas, K., Auzenbergs, M., De Villiers, M. J., Ferrari, M. J., Fraser, K., Fu, H., Hallett, T., Hinsley, W., Jit, M., Karachaliou, A., Moore, S. M., Nayagam, S., Papadopoulos, T., Perkins, T. A., Portnoy, A., … Gaythorpe, K. A. M. (2024). Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study. The Lancet Global Health, 12(4), e563–e571. Cite
Kang, H., Auzenbergs, M., Clapham, H., Maure, C., Kim, J.-H., Salje, H., Taylor, C. G., Lim, A., Clark, A., Edmunds, W. J., Sahastrabuddhe, S., Brady, O. J., & Abbas, K. (2024). Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study. The Lancet Infectious Diseases, S1473309923008101. Cite
Auzenbergs, M., Maure, C., Kang, H., Clark, A., Brady, O., Sahastrabuddhe, S., & Abbas, K. (2024). Programmatic considerations and evidence gaps for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: Stakeholder analysis. PLOS Neglected Tropical Diseases, 18(4), e0012075. Cite
Williams, S. V., Akande, T., & Abbas, K. (2024). Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria. PLOS ONE, 19(3), e0297326. Cite
Abbas, K., Yoo, K. J., Prem, K., & Jit, M. (2024). Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010–22: a modelling study. EClinicalMedicine, 102524. Cite
Ngwe Tun, M. M., Kyaw, A. K., Nwe, K. M., Myaing, S. S., Win, Y. T., Inoue, S., Takamatsu, Y., Urano, T., Thu, H. M., Hmone, S. W., Thant, K. Z., & Morita, K. (2023). Burden of Chikungunya Virus Infection during an Outbreak in Myanmar. Viruses, 15(8), 1734. Cite
Balingit, J. C., Dimamay, M. P. S., Suzuki, R., Matsuda, M., Xayavong, D., Ngwe Tun, M. M., Matias, R. R., Natividad, F. F., Moi, M. L., Takamatsu, Y., Culleton, R., Buerano, C. C., & Morita, K. (2024). Role of pre-existing immunity in driving the dengue virus serotype 2 genotype shift in the Philippines: A retrospective analysis of serological data. International Journal of Infectious Diseases, 139, 59–68. Cite
Paul, K. M. M., Simpson, S. V., Nundu, S. S., Arima, H., & Yamamoto, T. (2024). Genetic diversity of glutamate-rich protein (GLURP) in Plasmodium falciparum isolates from school-age children in Kinshasa, DRC. Parasitology International, 100, 102866. Cite
Mogasale, V., Sinha, A., John, J., Farooqui, H., Ray, A., Chantler, T., Mogasale, V., Dhoubhadel, B. G., Edmunds, W. J., Clark, A. D., & Abbas, K. (2024). Research Priorities to Support Typhoid Conjugate Vaccine Decision-Making in India: Evidence Assessment and Stakeholder Survey (SSRN Scholarly Paper No. 4714399). Cite
Parajulee, P., Lee, J.-S., Abbas, K., Cannon, J., Excler, J. L., Kim, J. H., & Mogasale, V. (2024). State transitions across the Strep A disease spectrum: scoping review and evidence gaps. BMC Infectious Diseases, 24(1), 108. Cite
Naylor, N. R., Hasso-Agopsowicz, M., Kim, C., Ma, Y., Frost, I., Abbas, K., Aguilar, G., Fuller, N. M., Robotham, J. V., & Jit, M. (2023). The Global Economic Burden of Antibiotic Resistant Infections and the Potential Impact of Bacterial Vaccines: A Modelling Study (SSRN Scholarly Paper No. 4676946). Cite
Murayama, H., Endo, A., & Yonekura, S. (2023). Estimation of waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics. Epidemics, 45, 100726. Cite
Ngwe Tun, M. M., Raini, S. K., Fernando, L., Gunawardene, Y., Inoue, S., Takamatsu, Y., Urano, T., Muthugala, R., Hapugoda, M., & Morita, K. (2023). Epidemiological evidence of acute transmission of Zika virus infection in dengue suspected patients in Sri-Lanka. Journal of Infection and Public Health, 16(9), 1435–1442. Cite
Nwe, K. M., Tun, M. M. N., Muthugala, R., Nabeshima, T., Balingit, J. C., Rajamanthri, L., Jayawardana, D., Attanayake, S., Inoue, S., Takamatsu, Y., Urano, T., & Morita, K. (2023). Clinical, Virological, and Immunological Features in Cosmopolitan Genotype DENV-2–Infected Patients during a Large Dengue Outbreak in Sri Lanka in 2017. The American Journal of Tropical Medicine and Hygiene, 109(4), 917–925. Cite
Ngwe Tun, M. M., Nwe, K. M., Balingit, J. C., Takamatsu, Y., Inoue, S., Pandey, B. D., Urano, T., Kohara, M., Tsukiyama-Kohara, K., & Morita, K. (2023). A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis. Vaccines, 11(12), 1857. Cite
Furuse, Y. (2024). Characteristics of retracted research papers before and during the COVID-19 pandemic. Frontiers in Medicine, 10. Cite
Yoshikawa, R., Kawakami, M., & Yasuda, J. (2023). The NSs protein of severe fever with thrombocytopenia syndrome virus differentially inhibits the type 1 interferon response among animal species. Journal of Biological Chemistry, 299(6), 104819. Cite
Nabeshima, T., Ngwe Tun, M. M., Thuy, N. T. T., Hang, N. L. K., Mai, L. T. Q., Hasebe, F., Takamatsu, Y., & Nagasaki University Vietnam Research Group. (2023). An outbreak of a novel lineage of dengue virus 2 in Vietnam in 2022. Journal of Medical Virology, 95(11), e29255. Cite
Fu, H., Abbas, K., Malvolti, S., Gregory, C., Ko, M., Amorij, J.-P., & Jit, M. (2023). Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation. BMJ Global Health, 8(11), e012204. Cite
Flandes, X., Hansen, C. A., Palani, S., Abbas, K., Bennett, C., Caro, W. P., Hutubessy, R., Khazhidinov, K., Lambach, P., Maure, C., Marshall, C., Rojas, D. P., Rosewell, A., Sahastrabuddhe, S., Tufet, M., Wilder-Smith, A., Beasley, D. W. C., Bourne, N., & Barrett, A. D. T. (2023). Vaccine value profile for Chikungunya. Vaccine. Cite
Qian, G. Y., Edmunds, W. J., Bausch, D. G., & Jombart, T. (2023). A mathematical model of Marburg virus disease outbreaks and the potential role of vaccination in control. BMC Medicine, 21(1), 439. Cite
Furuse, Y. (2023). Estimation of excess cardiovascular deaths after COVID-19 in 2020. The Journal of Infection, 87(1), e5–e7. Cite
Ngwe Tun, M. M., Kyaw, A. K., Nabeshima, T., Dumre, S. P., Soe, A. M., Nwe, K. M., Myaing, S. S., Lwin, E. P., Win, Y. T., Inoue, S., Takamatsu, Y., Urano, T., Thu, H. M., Thant, K. Z., Htun, Z. T., & Morita, K. (2023). Coinfection and circulation of chikungunya virus and dengue virus in pediatric patients in Myanmar, 2019. Microbes and Infection, 25(6), 105129. Cite
Rimal, S., Shrestha, S., Pandey, K., Nguyen, T. V., Bhandari, P., Shah, Y., Acharya, D., Adhikari, N., Rijal, K. R., Ghimire, P., Takamatsu, Y., Pandey, B. D., Fernandez, S., Morita, K., Ngwe Tun, M. M., & Dumre, S. P. (2023). Co-Circulation of Dengue Virus Serotypes 1, 2, and 3 during the 2022 Dengue Outbreak in Nepal: A Cross-Sectional Study. Viruses, 15(2), 507. Cite
Furuse, Y. (2023). Cartography of SARS-CoV-2 variants based on the susceptibility to therapeutic monoclonal antibodies. Journal of Medical Virology, 95(1), e28275. Cite
Qian, G. Y., Jombart, T., & John Edmunds, W. (2023). Assessing the feasibility of Phase 3 vaccine trials against Marburg Virus Disease: A modelling study. Vaccine: X, 14, 100321. Cite
Nguyen, T. V., Ngwe Tun, M. M., Cao, M. T., Dao, H. M., Luong, C. Q., Huynh, T. K. L., Nguyen, T. T. T., Hoang, T. N. D., Morita, K., Le, T. Q. M., Pham, Q. D., Takamatsu, Y., & Hasebe, F. (2023). Serological and Molecular Epidemiology of Chikungunya Virus Infection in Vietnam, 2017-2019. Viruses, 15(10), 2065. Cite
Cadarette, D., Ferranna, M., Cannon, J. W., Abbas, K., Giannini, F., Zucker, L., & Bloom, D. E. (2023). The full health, economic, and social benefits of prospective Strep A vaccination. Npj Vaccines, 8(1), 1–9. Cite